Vol. 41 No. 4 (2024)

Click for printable Cover

Published: 10-12-2024

  • Insights into the paradoxical effect of smoking on vasculitis: a comprehensive review

    DOI: https://doi.org/10.36141/svdld.v41i4.15557
    Alireza Khabbazi, Mehran Rahimi, Aida Malek Mahdavi, Rojin Farzaneh, Sara Daneshvar, Amirreza Naseri, Saman Beig Zali, Ehsan Nasiri
    e2024053

  • Pulmonary rehabilitation in connective tissue disease-associated interstitial lung disease: A systematic review

    DOI: https://doi.org/10.36141/svdld.v41i4.15633
    Irem Seleoglu, Aynur Demirel
    e2024061

  • Comparing the utility of lung function parameters and fractional exhaled nitric oxide in predicting lung cancer

    DOI: https://doi.org/10.36141/svdld.v41i4.14694
    Hongli Cao, Xianyang Chen, Yige Song, Teng Xue, Zhongwen Xue, Guosheng Zhang, Kun Wang, Zijin Liu
    e2024065

  • Diagnostic yield of a novel tracer 68Ga-citrate in sarcoidosis patients 68Ga-citrate PET/CT in sarcoidosis

    DOI: https://doi.org/10.36141/svdld.v41i4.15207
    Cuneyt Tetikkurt, Bahar Kubat, Haluk Burcak Sayman, Halil Yanardag, Muammer Bilir
    e2024064

  • Prolonged corticosteroid therapy and lung abnormalities in patients after severe COVID-19 pneumonia

    DOI: https://doi.org/10.36141/svdld.v41i4.14331
    Anja Ljilja Posavec, Daria Cvetković Kučić, Nikola Zagorec, Linda Malnar, Kristina Lalić, Marina Zelenika, Ivona Kovačevič, Dinka Kušter, Andreja Mutvar, Nevenka Piskač Živković
    e2024052

  • Interstitial lung disease: retrospective study of the prognostic impact of acute exacerbations

    DOI: https://doi.org/10.36141/svdld.v41i4.15198
    Joana Pacheco, Ana Isabel Santos, Maria Joana Catarata, Sara Freitas
    e2024051

  • Comparison of methotrexate and methylprednisolone as addition to antifibrotic therapy in progressive pulmonary fibrosis due to COVID-19

    DOI: https://doi.org/10.36141/svdld.v41i4.15614
    Buğra Kerget, Burcu Nur Gülbahar, İsmail Çınar, Fatih Alper, Leyla Sağlam
    e2024054

  • Prevalence of SARS-COV-2 infection and outcomes in Greek sarcoidosis patients

    DOI: https://doi.org/10.36141/svdld.v41i4.15661
    Ourania S. Kotsiou, Paraskevi Kirgou, Argyrios Tzouvelekis, Lykourgos Kolilekas, Effrosyni D. Manali , Spyros A. Papiris , Despina Papakosta, Katerina Antoniou, Ilias Papanikolaou, Paschalis Steiropoulos, Ioannis Tomos, Theodoros Karampitsakos, Anastasia Levounets, Evagelia Fouka, Georgios Spyropoulos, Semeli Mastrodimou, Ourania Papaioannou, Maria Kallieri, Nikoleta Kosmidou, Nikoleta Bizymi, Nikolaos G. Zikos , Ilias E. Dimeas , Foteini Malli, Zoe Daniil
    e2024055

  • Lung cancer in patients with pulmonary fibrosis: characteristics features and prognosis

    DOI: https://doi.org/10.36141/svdld.v41i4.15675
    Sibel Kara, Nesrin Mogulkoc, Gamze Kirkil, Erdogan Cetinkaya, Omer Ozbudak, Talat Kilic, Fatma Demirci Ucsular, Baris Demirkol, Dildar Duman, Gulistan Karadeniz, Nurhan Koksal, Yasemin Soyler, Hulya Gunbatar, Ozlem Oruc, Utku Tapan, Kubra Elif Akbas, Omer Selim Unat
    e2024050

  • Sarcoidosis in north African people: about 35 cases

    DOI: https://doi.org/10.36141/svdld.v41i4.15747
    Rahma Gargouri, Wafa Fenina, Mohamed Al Juaidi, Walid Feki, Hela Fendri, Sameh Msaed, Nedia Moussa, Zeineb Mnif, Samy Kammoun
    e2024060

  • Quality of life, fatigue and markers in sarcoidosis: A section from Turkey

    DOI: https://doi.org/10.36141/svdld.v41i4.15760
    Mustafa Ilteris Bardakci, Gulhan Ayhan Albayrak
    e2024049

  • Autoantibodies in sarcoidosis: Innocent bystander or promising biomarker for organ involvement?

    DOI: https://doi.org/10.36141/svdld.v41i4.16043
    Riccardo Pozzan, Francesco Salton, Paola Confalonieri, Liliana Trotta, Mariangela Barbieri, Nicolò Reccardini, Chiara Torregiani, Gianluca Screm, Michael Hughes, Elisa Baratella, Marco Confalonieri, Lucrezia Mondini, Barbara Ruaro
    e2024056

  • Eruptive cutaneous sarcoidosis – A rare phenomenon

    DOI: https://doi.org/10.36141/svdld.v41i4.16315
    Almog Badash, Lacey Zimmerman, Yonatan Hirsch, Nadera Sweiss, Roger Haber
    e2024058

  • Digital sarcoidosis with nail dystrophy

    DOI: https://doi.org/10.36141/svdld.v41i4.16349
    Michelle Sikora, Kristen I. Lo Sicco, Sara Stream, Avrom S. Caplan
    e2024059

  • Mandibular and periodontal involvement in sarcoidosis

    DOI: https://doi.org/10.36141/svdld.v41i4.15860
    Lauran Zeineddine, Divya Patel, Diana Gomez-Manjarres, Donald M. Cohen, Johnny F. Jaber
    e2024062

  • Sarcoidosis after Alemtuzumab therapy: Is Alemtuzumab posing a threat to its patients?

    DOI: https://doi.org/10.36141/svdld.v41i4.15873
    Misbah Nizamani
    e2024036

  • Comparative analysis of COVID-19-related mortality risk in chronic lower respiratory disease and interstitial lung disease

    DOI: https://doi.org/10.36141/svdld.v41i4.16139
    George W. Hafzalla, Hyein Ji, Niranjan Jeganathan
    e2024057

  • Online survey on existing sarcoidosis registries and biobanks: an ERN lung initiative.

    DOI: https://doi.org/10.36141/svdld.v41i4.16074
    Miriana D'alessandro, Tommaso Pianigiani, Laura Bergantini, Paolo Cameli, Elena Bargagli, Elisabetta Balestro, Eda Börner, Francesco Bonella
    e2024063